For Atrial Fibrillation Ablation, Dabigatran Reduces Major Bleeds
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events…
Rivaroxaban Reduces VTE Recurrence Compared with Aspirin
In patients at elevated risk for a recurrence of potentially life-threatening blood clots, a low dose of the oral blood-thinning medication rivaroxaban reduced recurrences more than three-fold compared…
Denosumab Found Safe in Long-Term Trial
A new study provides reassuring information about the short-term and long-term safety of denosumab, a monoclonal antibody that is used to treat postmenopausal osteoporosis.Adverse events that had been…
Study suggests evolucamab alongside statins can significantly cut cholesterol
A new class of cholesterol-lowering drug has been found to help patients cut their risk of cardiovascular disease, stroke and heart attack.In a trial of more than 27,000…
The evidence base for Hormone Replacement Therapy (HRT): what can we believe?
The ‘facts’ that most women and clinicians consider in making the decision to use, or not use, HRT are frequently wrong or incorrectly applied says Professor Robert D…